Rocket Lab (RKLB) shares traded in the low-to-mid $60s during the week of September 7, 2026, supported by operational momentum despite a sharp year-to-date decline from peaks near $150. Record Q2 revenue of $234 million, up 62% year-over-year, a $2.36 billion backlog, and more than $1 billion in recent contract wins highlighted execution strength in Electron launches and space systems. The September 11 “Happily Ever Faster” mission marked the company’s 16th Electron flight of 2026 and 95th overall, while new analyst initiations from Raymond James ($80 target) and others reinforced a Strong Buy consensus with average price targets near $110. Offsetting factors include persistent adjusted EBITDA losses, heavy Neutron development spending, and elevated valuation at roughly 50 times trailing revenue amid sector rotation away from high-growth space names. Upcoming Electron missions and Iridium acquisition progress remain key near-term catalysts for trader positioning.